跳至主要内容
临床试验/NCT02372292
NCT02372292已完成不适用

Value of Renal Vascular Doppler Sonography in Management of Decompensated Heart Failure

Ankara University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Alterations in the renal arterial resistivity index

研究概览

简要总结

Although the traditional determinant of renal dysfunction in heart failure was suggested as decreased cardiac output and renal hypo perfusion, recent studies have demonstrated the association of persistent systemic venous congestion and kidney dysfunction. Relief of the congestion has demonstrated to improve renal functions in decompensated heart failure. The current trial was set up to investigate the changes of renal venous impedance and renal arteriolar resistivity indices with diuretic therapy, in patients with congestive renal failure. The investigators asked whether measurement of renal venous impedance index or renal arteriolar resistivity index can guide the practice of diuretic therapy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Decompensated heart failure
  • Elevated serum creatinine levels on admission

排除标准

  • Atrial fibrillation
  • Obstructive uropathy
  • Patients with ascites
  • Patients who exposed the potential nephrotoxic drugs in the previous week (metformin, antibiotics, chemotherapeutics, iodinated contrast agents and non-steroidal anti-inflammatory agents)
  • Patients who needed positive inotropic agents

研究组 & 干预措施

Group 1

Active Comparator

Patients with type 1 cardiorenal syndrome who had improvement of renal functions along with diuretic therapy. Intravenous furosemide treatment.

干预措施: intravenous furosemide (Drug)

Group 2

Active Comparator

Patients with type 1 cardiorenal syndrome who did not have improvement of renal functions along with diuretic therapy. Intravenous furosemide treatment.

干预措施: intravenous furosemide (Drug)

结局指标

主要结局

Alterations in the renal arterial resistivity index

时间窗: during hospitalization, an expected average of 4 weeks.

Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.

次要结局

  • Alterations in the renal venous impedance index(during hospitalization, an expected average of 4 weeks.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Özgür Ulaş Özcan

MD

Ankara University

研究点 (1)

Loading locations...

相似试验